Cellebrite DI Current Ratio Growth & History (CLBT)
Cellebrite DI's current ratio was 1.56 for fiscal 2025.
View full Cellebrite DI company overviewCellebrite DI annual current ratio history
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.56 | −0.36 | −18.90% |
| 2024 | 2024-12-31 | 1.92 | 0.26 | +15.51% |
| 2023 | 2023-12-31 | 1.66 | 0.24 | +16.75% |
| 2022 | 2022-12-31 | 1.42 | −0.04 | −2.74% |
| 2021 | 2021-12-31 | 1.46 | −0.57 | −28.02% |
| 2020 | 2020-12-31 | 2.03 | — | — |
Cellebrite DI quarterly current ratio
Q4.20
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.62 | −0.34 | −17.20% |
| Q1 2026 | 2026-03-31 | 1.54 | −0.27 | −15.09% |
| Q4 2025 | 2025-12-31 | 1.56 | −0.36 | −18.90% |
| Q3 2025 | 2025-09-30 | 2.11 | — | — |
| Q2 2025 | 2025-06-30 | 1.96 | 0.21 | +11.84% |
| Q1 2025 | 2025-03-31 | 1.82 | — | — |
| Q4 2024 | 2024-12-31 | 1.92 | 0.26 | +15.51% |
| Q2 2024 | 2024-06-30 | 1.75 | 0.10 | +5.97% |
| Q4 2023 | 2023-12-31 | 1.66 | 0.24 | +16.75% |
| Q2 2023 | 2023-06-30 | 1.65 | 0.30 | +22.07% |
| Q4 2022 | 2022-12-31 | 1.42 | −0.04 | −2.74% |
| Q2 2022 | 2022-06-30 | 1.35 | — | — |
| Q4 2021 | 2021-12-31 | 1.46 | −0.57 | −28.02% |
| Q4 2020 | 2020-12-31 | 2.03 | — | — |
Cellebrite DI current ratio trends
Over the last five fiscal years, Cellebrite DI's current ratio decreased from 2.03 to 1.56, a change of −0.48. The latest reported quarter, Q2 2026, shows 1.62.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cellebrite DI source filings ↗